Related Experiment Video

Updated: Dec 23, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

11.8K

Primary Cardiac Diffuse Large B-cell Lymphoma Promptly and Safely Diagnosed with Pericardial Effusion Cytology

Haruna Fukuzaki1, Kentaro Fukuda2, Akihiro Sato2

  • 1Department of Nephrology, Juntendo University Faculty of Medicine, Japan.

Internal Medicine (Tokyo, Japan)
|May 1, 2020
PubMed

Insights

Primary cardiac lymphoma, a rare cancer, poses sudden cardiac death risks. Pericardial effusion cytology enabled prompt diagnosis and successful treatment with rituximab chemotherapy.

Area of Science:

  • Cardiology
  • Oncology
  • Hematology

Background:

  • Primary cardiac lymphoma is an exceptionally rare malignancy with a significant risk of sudden cardiac death.
  • Early diagnosis and intervention are critical for improving patient outcomes in primary cardiac lymphoma.

Observation:

  • A 68-year-old female presented with symptoms of shortness of breath and peripheral edema.
  • Echocardiography revealed a large pericardial effusion and a mass on the right atrium and ventricle walls.
  • Pericardial effusion cytology identified diffuse large B-cell lymphoma.

Findings:

  • Pericardial effusion cytology proved to be a safe and effective method for the prompt diagnosis of primary cardiac lymphoma.
  • The patient received chemotherapy with rituximab, leading to a favorable clinical response.

Implications:

  • This case highlights the diagnostic utility of pericardial effusion cytology in suspected primary cardiac lymphoma.
  • Prompt diagnosis and treatment, including rituximab-based chemotherapy, can lead to positive clinical outcomes in this rare condition.
  • Further research into diagnostic and therapeutic strategies for primary cardiac lymphoma is warranted.

Keywords:
chemotherapy with rituximabpericardial effusion cytologyprimary cardiac lymphomaprimary cardiac tumor

More Related Videos

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.9K
Isolation and Identification of Extravascular Immune Cells of the Heart08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

13.8K

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
215
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
181
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
335